A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS	brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Phase 2	2026-07-29		NCT07084012

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Tiantan Hospital	307
Shenzhen Wingor Biotechnology Co., Ltd.	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Tiantan Hospital, Capital Medical University	Beijing	China	59

Clinical trials